{
     "PMID": "7991451",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19950110",
     "LR": "20131121",
     "IS": "0196-9781 (Print) 0196-9781 (Linking)",
     "VI": "15",
     "IP": "6",
     "DP": "1994",
     "TI": "Estrogen increases affinity of oxytocin receptors in the medial preoptic area-anterior hypothalamus.",
     "PG": "1079-84",
     "AB": "Analysis of binding data from saturation experiments using a radiolabeled oxytocin antagonist ([125I]OTA) demonstrated an increase in binding affinity after treatment with 5 micrograms estradiol benzoate (EB) for 3 days in membrane fractions from the medial preoptic area-anterior hypothalamus (MPOA-AH) of ovariectomized (OVX) rats. Analysis of data from competition experiments revealed high- and low-affinity [125I]OTA binding sites in the MPOA-AH, the medial basal hypothalamus (MBH), and hippocampus of OVX controls. Three days of EB treatment reduced low-affinity binding sites in the MPOA-AH and MBH, but not in the hippocampus. Treatment of membrane fractions from the MPOA-AH of oil-treated OVX rats in vitro with 100 nM OT or with estrogen or progesterone conjugated to bovine serum albumin (E-BSA and P-BSA) also reduced low-affinity [125I]OTA binding sites but BSA alone did not.",
     "FAU": [
          "Caldwell, J D",
          "Walker, C H",
          "Pedersen, C A",
          "Barakat, A S",
          "Mason, G A"
     ],
     "AU": [
          "Caldwell JD",
          "Walker CH",
          "Pedersen CA",
          "Barakat AS",
          "Mason GA"
     ],
     "AD": "Brain and Development Research Center, School of Medicine, University of North Carolina at Chapel Hill 27599.",
     "LA": [
          "eng"
     ],
     "GR": [
          "HD-24086/HD/NICHD NIH HHS/United States",
          "HD-25255/HD/NICHD NIH HHS/United States",
          "MH-33127/MH/NIMH NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "United States",
     "TA": "Peptides",
     "JT": "Peptides",
     "JID": "8008690",
     "RN": [
          "0 (Estrogens)",
          "0 (Receptors, Oxytocin)",
          "114056-26-7 (vasotocin, (beta-mercapto-beta,beta-cyclopentamethylenepropionic",
          "acid)-O-methyl-Tyr(2)-Thr(4)-Orn(8)-Tyr(9)-NH2)",
          "4TI98Z838E (Estradiol)",
          "W6S6URY8OF (Vasotocin)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Binding, Competitive",
          "Estradiol/*analogs & derivatives",
          "Estrogens/*pharmacology",
          "Female",
          "Hippocampus/metabolism",
          "Membranes/metabolism",
          "Ovariectomy",
          "Preoptic Area/*metabolism",
          "Protein Binding",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptors, Oxytocin/*metabolism",
          "Vasotocin/*analogs & derivatives/metabolism"
     ],
     "EDAT": "1994/01/01 00:00",
     "MHDA": "1994/01/01 00:01",
     "CRDT": [
          "1994/01/01 00:00"
     ],
     "PHST": [
          "1994/01/01 00:00 [pubmed]",
          "1994/01/01 00:01 [medline]",
          "1994/01/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Peptides. 1994;15(6):1079-84.",
     "term": "hippocampus"
}